HAVE YOU EVER DETOXED AND FELT WORSE? Your DNA might be why and your kidneys are paying the price

You did everything right – broccoli every day, turmeric in your smoothie, a liver support supplement your nutritionist recommended. And instead of feeling better, you felt foggy, exhausted, headachy, maybe a little wired and hollow at the same time. So you stopped, assumed detoxing “wasn’t for you,” and moved on.

That experience has a precise biochemical explanation. And for a significant proportion of people, it comes down to two genetic variants that most GPs have never mentioned: MTHFR and COMT. These variants don’t just affect how you feel after a detox. They directly affect your kidney health and the research is specific, peer-reviewed, and almost entirely absent from routine medical appointments.

WHY PHASE I LIVER DETOX CAN MAKE YOU FEEL WORSE BEFORE IT MAKES YOU BETTER

Most people understand liver detoxification as a single process – toxins go in, toxins come out. The reality is considerably more complex and understanding it is the key to understanding why your genetics matter.

Phase I detoxification converts stored toxins – environmental chemicals, metabolic by-products, hormones, medications, into reactive intermediates. These are chemically activated compounds that are, in many cases, more reactive and potentially more damaging than the original toxin. Phase I essentially makes toxins more dangerous before making them safe.

Phase II then neutralises these reactive intermediates through six conjugation pathways: methylation, sulphation, glucuronidation, glutathione conjugation, acetylation, and amino acid conjugation. Each pathway handles specific compounds and depends on different nutritional co-factors.

When Phase II cannot keep pace with Phase I because one or more of these pathways is genetically impaired or nutritionally depleted, reactive intermediates accumulate. They have nowhere to go…

And you feel it: fatigue, brain fog, headaches, skin reactions, heightened chemical sensitivity. You think you’re detoxing, when actually, you’re accumulating.

MTHFR: the Methylation engine with a speed limiter

Of the six Phase II pathways, methylation receives the most attention in functional medicine and for specific reasons. It’s not the only pathway, but it is the one most commonly impaired by genetics, the one that produces SAMe (S-adenosylmethionine), which feeds multiple other biological systems, and the one responsible for clearing the most hormonally active compounds: oestrogen metabolites, catecholamines, and homocysteine.

MTHFR is the gene that converts folate into the active form your body can actually use, the fuel that keeps the methylation cycle running. Two common variants, C677T and A1298C, slow this conversion down by 30–70% depending on how many copies you carry. And this is not rare: it’s estimated that 40–60% of people carry some version of these variants without ever knowing it.

The consequences cascade – reduced methylation capacity means Phase II struggles to neutralise what Phase I activates. Homocysteine rises, an amino acid that requires methylation to be cleared. B vitamins, particularly folate and B12, are depleted faster. And the reactive intermediates generated by driving Phase I hard with cruciferous vegetables, turmeric, and liver supplements have nowhere to go.

What MTHFR does to your KIDNEYS

The kidney connection is specific, research-backed, and almost entirely absent from routine clinical conversations.

• Homocysteine damages renal vasculature. Research published in Kidney International found that the MTHFR C677T genotype is associated with cardiovascular disease in end-stage renal disease and may be a more meaningful risk marker than homocysteine measurement alone. (Wrone et al., 2001)
• MTHFR A1298C independently predicts GFR decline. A study across two patient cohorts – the African-American Study of Kidney Disease and Hypertension (AASK) and the Veterans Affairs Hypertension Cohort – found that the A1298C polymorphism is independently associated with progressive loss of kidney filtration rate over time. (Bostom et al., PMC3350339)
• Oxidative stress in kidney tubule cells. Impaired methylation allows reactive intermediates to accumulate in kidney tubular cells, driving the oxidative stress and inflammation that underpin chronic kidney disease progression.

COMT: When your body cannot clear its own STRESS Hormones

COMT is the enzyme responsible for breaking down catecholamines – adrenaline, noradrenaline, and dopamine, as well as catechol oestrogens and environmental chemicals processed through the liver. A common variant, Val158Met (rs4680), reduces enzyme activity significantly, meaning these biologically active compounds linger in the system rather than being efficiently cleared.

Slow COMT creates a specific cascade: adrenaline and noradrenaline accumulate, sustaining sympathetic nervous system activation. Blood pressure rises. Catechol oestrogens recirculate rather than being excreted – a pattern that shows up clinically as oestrogen dominance, chemical sensitivity, and mood instability. And because COMT uses SAMe to do its clearing work, it competes directly with the methylation cycle, further depleting the methyl donors that MTHFR-impaired individuals are already struggling to produce.

The COMT–Kidney connection nobody talks about

Here is what most people including many practitioners do not know: COMT is expressed directly in kidney tissue. The soluble form of the enzyme (S-COMT) is produced by the liver, kidneys, and blood, where it helps control hormone levels. Within the kidney itself, COMT is active in the distal nephron segments, where it metabolises renal dopamine – the locally produced dopamine that regulates sodium excretion, fluid balance, and systemic blood pressure. (MedlinePlus Genetics; Jose et al., 2021)

The implications are significant:

• Renal dopamine directly regulates sodium handling. Your kidneys synthesise their own dopamine in the proximal tubules, independent of the nervous system. COMT degrades this dopamine in the distal nephron. A slow COMT variant alters this balance, affecting electrolyte excretion and blood pressure regulation at the kidney level.
• Catecholamine excess drives hypertensive kidney damage. Research shows that decreased COMT expression in the renal cortex is associated with hypertensive kidney damage. When catecholamines are not efficiently cleared, renal vascular resistance rises and glomerular perfusion is compromised. (Fujita et al., PMID: 19966533)
• CKD and catecholamine clearance form a vicious cycle. As kidney disease progresses, norepinephrine clearance drops by 20-40%. For someone already carrying a slow COMT variant, declining kidney function further impairs catecholamine clearance, accelerating the very cardiovascular and renal damage that caused the decline in the first place. (Circulation, Armando et al., 2008)

MTHFR + COMT тogether – One backed-up system

When both variants are present, which is common, since they share methylation pathways.

The effect is not additive, it is compounding.

MTHFR impairs the methylation that COMT depends on. COMT then accumulates the catecholamines and oestrogen metabolites that methylation would have cleared. Phase I, driven by well-intentioned nutritional support, activates more reactive intermediates than Phase II can handle. The liver-biliary pathway becomes congested and the KIDNEYS absorb the overflow.

The clinical picture this creates is not one of a single identifiable disease. It looks like chronic fatigue, like oestrogen dominance, like being sensitive to everything. Like never quite clearing, never quite recovering, never quite feeling well even when doing all the right things. These are not separate problems. They are the same backed-up system expressing itself at every available outlet.

Homeopathic Drainage remedies: opening the pathways that make detox safe

Understanding this biochemical picture reframes what holistic support actually needs to do. The answer is not to stop eating cruciferous vegetables or to avoid liver-supporting nutrition. It is to ensure the drainage pathways are open before and during nutritional support, so that what Phase I activates can actually get out of the body rather than recirculating through it.

This is the specific role of homeopathic drainage remedies in an integrative approach. Working at the energetic layer that sits beneath biochemistry at the level of the body’s own regulatory intelligence, drainage remedies do not replace nutritional support. They prepare and maintain the elimination channels through which nutritional inputs can actually do their work. For individuals carrying MTHFR or COMT variants, this drainage layer is not an optional refinement. It is what separates a detox that heals from a detox that accumulates.

The principle at the heart of integrative medicine at its most precise: Food feeds the pathway, Homeopathy opens it. Three remedies illustrate this particularly well in the context of MTHFR and COMT:

Berberis — Kidney drainage and the Functional Medicine crossover

Berberis is the primary kidney drainage remedy here. It supports the renal pelvis, clears metabolic waste through the urinary tract, and drains the biliary tree simultaneously, so the liver and kidneys are working together rather than one picking up the slack for the other. This is especially valuable for MTHFR carriers, where both organs are already under greater demand. Worth noting: berberine – the functional medicine compound that shares its name and plant family, is one of the most studied natural AMPK activators in renal health research. Two traditions, same terrain.

Chelidonium — The Liver-Biliary traffic controller

Chelidonium keeps the liver-biliary pathway moving, ensuring that what Phase I activates can actually exit the body rather than backing up. For anyone with MTHFR-impaired methylation, this matters enormously: the reactive intermediates Phase I generates need a clear route out. When Chelidonium is used alongside cruciferous vegetables, milk thistle, and turmeric, those inputs finally have somewhere to go. It also directly supports liver detoxification including the clearance of hormones, inflammatory metabolites, and environmental toxins, which is precisely where COMT slowness creates the most congestion.

Sarsaparilla — Lymphatic drainage and Uric Acid clearance

Sarsaparilla supports lymphatic drainage and uric acid clearance, both particularly relevant when methylation is impaired. Uric acid builds up when metabolic waste is being mobilised faster than it can exit, and a sluggish lymphatic system adds to the kidneys’ filtration burden at exactly the wrong moment. Sarsaparilla opens that upstream channel so the kidneys aren’t compensating alone and it’s especially useful where uric acid accumulation is a concern, whether from genetics, diet, or a deeper detox phase.

Why functional DNA testing changes everything

The functional nutrition and homeopathic approach described here is effective. But it becomes exponentially more targeted when it is built on the actual genetic profile of the individual. Knowing whether someone carries C677T or A1298C in MTHFR, and in what combination, determines the degree of methylation support required. Knowing their COMT status determines how aggressively to support catecholamine clearance and oestrogen metabolism. Knowing both together determines the precise hierarchy of support – what to open first, what to add second, and what nutritional inputs to prioritise.

Standard kidney function tests – eGFR, serum creatinine, are reactive. They measure damage after it has occurred, often after 60–90% of function has already been lost. Functional DNA testing is preventive. It reveals the genetic terrain on which kidney health will be either protected or eroded over a lifetime. The MTHFR A1298C variant does not announce itself until GFR has been declining for years. By the time the blood test flags it, the window for epigenetic intervention has been narrowing for decades.

A personalised plan built on DNA results addresses the body as it actually is, not as population averages suggest it should be. That is the foundation of genuinely integrative medicine.

If you have ever detoxed and felt worse, you were not doing it wrong. You were doing it without the genetic context that would have told you how to do it right.

MTHFR and COMT variants are not diagnoses, they are information. With the right interpretation and the right integrated support – targeted nutrition, homeopathic drainage, and epigenetically-informed lifestyle choices, they become a roadmap rather than a sentence. Your kidneys, your liver, and every cell that depends on your body’s ability to clear what it no longer needs will function differently when that system is finally allowed to flow.